fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Blood pressure lowering drugs given in acute stage of stroke treatment lack efficacy

Written by | 13 May 2014

by Bruce Sylvester – Researchers report that administering blood pressure lowering drugs to patients in the first 48 hours after a stroke does not lower the risk of… read more.

Cbl-b, a target for drugs used to treat allergic asthma

Written by | 7 May 2014

Enzyme’s role is to ‘throw away’ protein if it overstays its welcome during immune response.  An enzyme that helps maintain immune system function by “throwing away” a specific… read more.

Pain treatment can reduce agitation in people with dementia

Written by | 2 May 2014

Thirty five million people worldwide have dementia, and this number is expected to increase to 115 million by 2050. Agitation and aggression are common in people with dementia,… read more.

ACC 2014 Report: Bariatric surgery vs. intensive medical therapy for uncontrolled diabetes: STAMPEDE Trial

Written by | 30 Apr 2014

by Bruce Sylvester – For managing uncontrolled type 2 diabetes in obese patients, gastric bypass and sleeve gastrectomy are each more effective than intensive medical therapy alone.

ACC 2014 Report: Intra-aortic balloon pump may have broader potential

Written by | 25 Apr 2014

The most frequently used mechanical circulatory assist device in the world may have untapped potential, physicians say.  One of many uses for the intra-aortic balloon pump is helping… read more.

ACC 2014 Report: ACE Inhibitors better than ARBs in CV patients with diabetes

Written by | 23 Apr 2014

Report from the ACC Annual Scientific Meeting, 29 – 31 March 2014 in Washington.   Angiotensin-converting-enzyme (ACE) inhibitors are associated with reduced mortality and cardiovascular events in patients… read more.

BTS Report 2014: Variability: does it impact outcomes?

Written by | 18 Apr 2014

Maria Dalby reporting on the Oral Presentation by Marc Clancy, Western Infirmary, Glasgow – Although the mainstay of clinical immunosuppression since the 1980s, calcineurin inhibitors (CNIs) are narrow… read more.

BTS Report 2014: Pharma no more: does the advent of generics spell the end of Pharma-funded prospective trials in transplantation?

Written by | 18 Apr 2014

Maria Dalby reporting on the Oral Presentation by Teun van Gelder, Erasmus Medical Centre Rotterdam, the Netherlands – Increasing use of generic drugs, escalating research and development costs… read more.

BTS 2014 Report: Protecting the allograft – preventing and treating chronic antibody-mediated rejection

Written by | 15 Apr 2014

Maria Dalby reporting from the annual British Transplantation Society meeting in Glasgow by Anthony Dorling, King’s College London – Chronic rejection is a major cause of graft failure… read more.

Researchers develop a new drug to combat measles

Written by | 14 Apr 2014

A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers… read more.

Traditional Chinese herbal medicaton found comparable to prescription drugs for control of pre-diabetes

Written by | 11 Apr 2014

by Bruce Sylvester – A traditional Chinese herbal medication appears to slow progression from pre-diabetes to diabetes, and at a rate similar to prescription treatments, researchers reported in… read more.

NSAIDs don’t increase miscarriage risk

Written by | 10 Apr 2014

by Bruce Sylvester – Pregnant women who take non-steroidal anti-inflammatory drugs do not increase their risk of miscarriages, researchers report in a study published on Feb. 3, 2014… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.